Jiangsu Hengrui Medicine
600276.SS
#467
Rank
โ‚น3.711 T
Marketcap
โ‚น581.86
Share price
-1.00%
Change (1 day)
5.01%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): โ‚น7.46

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น7.67. In 2022 the company made an earnings per share (EPS) of โ‚น7.65 a decrease over its 2021 EPS that were of โ‚น9.23.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น7.46-2.48%
2022โ‚น7.65-17.1%
2021โ‚น9.23-24.44%
2020โ‚น12.2120.3%
2019โ‚น10.1525.58%
2018โ‚น8.0827.55%
2017โ‚น6.3421.64%
2016โ‚น5.2113.57%
2015โ‚น4.5939.86%
2014โ‚น3.2821.33%
2013โ‚น2.7017.7%
2012โ‚น2.3025.56%
2011โ‚น1.8326.22%
2010โ‚น1.4510.3%
2009โ‚น1.3157.92%
2008โ‚น0.8311.06%
2007โ‚น0.7585.81%
2006โ‚น0.4087.94%
2005โ‚น0.2133.97%
2004โ‚น0.1629.78%
2003โ‚น0.1219.78%
2002โ‚น0.10